6prz: Difference between revisions

No edit summary
No edit summary
 
Line 3: Line 3:
<StructureSection load='6prz' size='340' side='right'caption='[[6prz]], [[Resolution|resolution]] 2.80&Aring;' scene=''>
<StructureSection load='6prz' size='340' side='right'caption='[[6prz]], [[Resolution|resolution]] 2.80&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[6prz]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PRZ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6PRZ FirstGlance]. <br>
<table><tr><td colspan='2'>[[6prz]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_virus_T4 Escherichia virus T4] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6PRZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6PRZ FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=JTZ:(2S)-1-[(1-METHYLETHYL)AMINO]-3-(2-PROP-2-EN-1-YLPHENOXY)PROPAN-2-OL'>JTZ</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.8&#8491;</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ADRB2, ADRB2R, B2AR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=JTZ:(2S)-1-[(1-METHYLETHYL)AMINO]-3-(2-PROP-2-EN-1-YLPHENOXY)PROPAN-2-OL'>JTZ</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6prz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6prz OCA], [http://pdbe.org/6prz PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6prz RCSB], [http://www.ebi.ac.uk/pdbsum/6prz PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6prz ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6prz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6prz OCA], [https://pdbe.org/6prz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6prz RCSB], [https://www.ebi.ac.uk/pdbsum/6prz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6prz ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/ADRB2_HUMAN ADRB2_HUMAN]] Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine.  
[https://www.uniprot.org/uniprot/D9IEF7_BPT4 D9IEF7_BPT4] [https://www.uniprot.org/uniprot/ADRB2_HUMAN ADRB2_HUMAN] Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 19: Line 19:
</div>
</div>
<div class="pdbe-citations 6prz" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 6prz" style="background-color:#fffaf0;"></div>
==See Also==
*[[Adrenergic receptor 3D structures|Adrenergic receptor 3D structures]]
*[[Lysozyme 3D structures|Lysozyme 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Escherichia virus T4]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Batyuk, A]]
[[Category: Batyuk A]]
[[Category: Cherezov, C]]
[[Category: Cherezov C]]
[[Category: Gati, C]]
[[Category: Gati C]]
[[Category: Han, G W]]
[[Category: Han GW]]
[[Category: Ishchenko, A]]
[[Category: Ishchenko A]]
[[Category: Iwata, S]]
[[Category: Iwata S]]
[[Category: Joti, Y]]
[[Category: Joti Y]]
[[Category: Li, C]]
[[Category: Li C]]
[[Category: Liu, W]]
[[Category: Liu W]]
[[Category: Moraes, I]]
[[Category: Moraes I]]
[[Category: Nakane, T]]
[[Category: Nakane T]]
[[Category: Nango, E]]
[[Category: Nango E]]
[[Category: Shiriaeva, A]]
[[Category: Shiriaeva A]]
[[Category: Stauch, B]]
[[Category: Stauch B]]
[[Category: Tanaka, R]]
[[Category: Tanaka R]]
[[Category: Tono, K]]
[[Category: Tono K]]
[[Category: Weierstall, U]]
[[Category: Weierstall U]]
[[Category: Zatsepin, N A]]
[[Category: Zatsepin NA]]
[[Category: Alprenolol]]
[[Category: B2ar]]
[[Category: Beta2ar]]
[[Category: Complex-lcp method]]
[[Category: Drug design]]
[[Category: Gpcr]]
[[Category: Lcp-sfx]]
[[Category: Ligand exchange]]
[[Category: Membrane protein]]
[[Category: Sbdd]]
[[Category: Xfel]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA